Skip to main content

NASDAQ:MLND Stock Forecast, Price Targets (Buy or Sell) | MLND Millendo Therapeutics Analyst Ratings

To assess an issuer's standing in the credit markets, we may look at factors such as equity, debt, and credit default swaps (CDS) trading levels, where available, relative to peers and market averages. For example, lower-than-average debt trading levels or widening rating-adjusted spreads relative to market averages may indicate decreasing market confidence about a company's prospects and ability to meet its debt maturities. As a result, the company could have increased difficulty accessing the capital markets.

We estimate MLND Millendo Therapeutics stock forecast parameters by: Running Moving Average (RMA) with Factor

MLND Millendo Therapeutics Stock Forecast (Buy or Sell) as of 10 Apr 2022 for (n+3m)

Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network with Running Moving Average (RMA) and Factor. Machine Learning based stock forecast (n+3m) for MLND Millendo Therapeutics as below:

Time series to forecast n: 10 Apr 2022 for (n+3m)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %

 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |